Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Bacil Pharma Share Price
Bacil Pharma Share Pric...
Bacil Pharma share price insights
Bacil Pharma Ltd. share price moved up by 1.95% from its previous close of Rs 18.41. Bacil Pharma Ltd. stock last traded price is 18.77
Share Price Value Today/Current/Last 18.77 Previous Day 18.41
Key Metrics
PE Ratio (x) | -100.14 | ||||||||||
EPS - TTM (₹) | -0.19 | ||||||||||
MCap (₹ Cr.) | 11.06 | ||||||||||
Sectoral MCap Rank | 167 | ||||||||||
PB Ratio (x) | 8.94 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.00 | ||||||||||
VWAP (₹) | 18.77 | ||||||||||
52W H/L (₹) |
Bacil Pharma Share Price Returns
1 Day | 1.95% |
1 Week | 19.1% |
1 Month | 2.18% |
3 Months | -22.76% |
1 Year | N.A. |
3 Years | N.A. |
5 Years | 726.87% |
Bacil Pharma News & Analysis
Announcement under Regulation 30 (LODR)-Change in Management
AnnouncementsAnnouncement under Regulation 30 (LODR)-Change in Directorate
AnnouncementsBoard Meeting Outcome for Outcome Of The Board Meeting Dated 28.08.2024.
AnnouncementsAnnouncement under Regulation 30 (LODR)-Newspaper Publication
Announcements
Bacil Pharma Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Bacil Pharma Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 0.01 0.02 0.03 0.03 0.05 Total Income Growth (%) -49.06 -35.56 14.24 -39.50 460.00 Total Expenses 0.04 0.06 0.06 0.04 0.03 Total Expenses Growth (%) -27.39 7.68 42.18 33.44 -64.30 EBIT -0.03 -0.04 -0.02 -0.01 0.02 EBIT Growth (%) - - - -166.09 - Profit after Tax (PAT) -0.03 -0.04 -0.02 -0.01 0.02 PAT Growth (%) - - - -166.09 - EBIT Margin (%) -314.81 -191.04 -74.16 -39.93 36.55 Net Profit Margin (%) -314.81 -191.04 -74.16 -39.93 36.55 Basic EPS (₹) -0.06 -0.07 -0.04 -0.02 0.03 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 1.33 1.13 1.27 4.09 4.11 Total Assets Growth (%) 17.70 -11.02 -68.95 -0.49 -9.67 Total Liabilities 0.11 0.03 0.05 2.70 2.72 Total Liabilities Growth (%) 266.67 -40.00 -98.15 -0.74 3.03 Total Equity 1.21 1.10 1.22 1.39 1.39 Total Equity Growth (%) 10.00 -9.84 -12.23 0.00 -27.23 Current Ratio (x) 0.46 8.19 10.63 1.04 1.02 Total Debt to Equity (x) 0.08 0.02 0.03 0.13 0.12 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 0.00 -0.15 -4.01 -0.40 -0.38 Net Cash used in Investing Activities 0.08 -0.12 3.81 0.53 0.39 Net Cash flow from Financing Activities -0.06 0.06 0.33 -0.07 -0.06 Net Cash Flow 0.01 -0.20 0.13 0.06 -0.05 Closing Cash & Cash Equivalent 0.04 0.03 0.23 0.10 0.04 Closing Cash & Cash Equivalent Growth (%) 44.18 -87.47 131.98 132.67 -52.46 Total Debt/ CFO (x) -33.93 -0.14 -0.01 -0.44 -0.45 All figures in Rs Cr, unless mentioned otherwise
Insights
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -4.87 -9.26 -315.24 -17.19 -22.73 Return on Capital Employed (%) -4.86 -9.26 -315.26 -17.22 -22.76 Return on Assets (%) -4.45 -9.03 -303.54 -5.85 -7.67 Interest Coverage Ratio (x) 0.00 0.00 0.00 0.00 0.00 Asset Turnover Ratio (x) - - - 0.00 0.00 Price to Earnings (x) -163.93 -35.21 -0.97 -8.53 -3.42 Price to Book (x) 7.87 3.25 3.06 1.46 0.78 EV/EBITDA (x) -168.53 -35.97 -0.92 -9.00 -3.91 EBITDA Margin (%) 0.00 0.00 0.00 0.00 0.00
Bacil Pharma Peer Comparison
Bacil Pharma Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Bacil Pharma Board Meeting/AGM
Bacil Pharma Dividends
- Others
Meeting Date Announced on Purpose Details Aug 14, 2024 Aug 07, 2024 Board Meeting Quarterly Results May 21, 2024 May 14, 2024 Board Meeting Audited Results Feb 13, 2024 Feb 05, 2024 Board Meeting Quarterly Results Nov 10, 2023 Nov 02, 2023 Board Meeting Quarterly Results Sep 16, 2023 Aug 24, 2023 AGM A.G.M. Dividend announcements are not available.
No other corporate actions details are available.
About Bacil Pharma
Bacil Pharma Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 11.06 Crore) operating in Pharmaceuticals sector. Bacil Pharma Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2023. Show More
Executives
Auditors
- SS
Suman Shah
Non Executive DirectorLJLalit Jain
Ind. Non-Executive DirectorSSShirish Shetya
Ind. Non-Executive DirectorPSPrakash Shah
DirectorShow More - Laxmikant Kabra & Co.A W Ketkar & Co
Industry
Key Indices Listed on
-
Address
71, Laxmi Building,Sir P.M. Road,Fort,Mumbai, Maharashtra - 400001
More Details
FAQs about Bacil Pharma share
- 1. What's the Bacil Pharma share price today?Bacil Pharma share price was Rs 18.77 as on 29 Aug, 2024, 03:32 PM IST. Bacil Pharma share price was up by 1.95% based on previous share price of Rs 17.54. Bacil Pharma share price trend:
- Last 3 Months: Bacil Pharma share price moved down by 22.76%
- Last 12 Months: Bacil Pharma share price moved remain unchanged N.A.
- Last 3 Years: Bacil Pharma Share price moved remain unchanged by N.A.
- 2. What are the returns for Bacil Pharma share?Return Performance of Bacil Pharma Shares:
- 1 Week: Bacil Pharma share price moved up by 19.10%
- 3 Month: Bacil Pharma share price moved down by 22.76%
- 6 Month: Bacil Pharma share price moved up by 80.48%
- 3. What's the market capitalization of Bacil Pharma?Market Capitalization of Bacil Pharma stock is Rs 11.06 Cr.
- 4. What is the PE & PB ratio of Bacil Pharma?The PE ratio of Bacil Pharma stands at -98.22, while the PB ratio is 9.91.
- 5. What are the Bacil Pharma quarterly results?Total Revenue and Earning for Bacil Pharma for the year ending 2024-03-31 was Rs 0.13 Cr and Rs -0.06 Cr on Standalone basis. Last Quarter 2024-06-30, Bacil Pharma reported an income of Rs 0.01 Cr and loss of Rs -0.03 Cr.
- 6. What is 52 week high/low of Bacil Pharma share price?Bacil Pharma share price saw a 52 week high of Rs 29.21 and 52 week low of Rs 4.68.
- 7. What are the key metrics to analyse Bacil Pharma Share Price?Bacil Pharma share can be quickly analyzed on following metrics:
- Stock's PE is -100.14
- Price to Book Ratio of 8.94
- 8. Who are the key owners of Bacil Pharma stock?
- Promoter holding has not changed in last 9 months and holds 42.67 stake as on 30 Jun 2024
- Other investor holding has not changed in last 9 months and holds 57.33 stake as on 30 Jun 2024
- 9. Who are the peers for Bacil Pharma in Pharmaceuticals sector?Within Pharmaceuticals sector Bacil Pharma, Welcure Drugs & Pharmaceuticals Ltd., Chemo Pharma Laboratories Ltd., Unjha Formulations Ltd., Kobo Biotech Ltd., Adline Chem Lab Ltd., Parmax Pharma Ltd., MPS Pharma Ltd., Norris Medicines Ltd., Colinz Laboratories Ltd. and Beryl Drugs Ltd. are usually compared together by investors for analysis.
Trending in Markets
Bacil Pharma Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.